Schedule I Controlled Substance

A Schedule I Controlled Substance represents a category of drugs designated by federal law as having a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.

Schedule I Controlled Substance

Key Takeaways

  • Schedule I Controlled Substances are federally classified as having the highest potential for abuse.
  • These substances currently lack any accepted medical use in treatment within the United States.
  • Common examples include heroin, LSD, MDMA (ecstasy), and federally, marijuana.
  • The classification is determined by criteria set forth in the federal Controlled Substances Act.
  • Possession, manufacture, and distribution of these substances carry severe legal penalties.

What is a Schedule I Controlled Substance?

A Schedule I Controlled Substance refers to a classification of drugs under the federal Controlled Substances Act (CSA) that are deemed to have the highest potential for abuse among all controlled substances. This designation signifies that, according to federal law, these substances currently have no accepted medical use in treatment in the United States and lack accepted safety for use under medical supervision. The classification is a critical component of drug regulation, influencing research, prescription practices, and legal penalties associated with these substances.

The criteria for a Schedule I classification are stringent, emphasizing both the substance’s potential for abuse and its medical utility. Unlike other schedules, Schedule I substances cannot be legally prescribed or administered by a physician for medical purposes in the U.S., although limited research use may be permitted under strict federal protocols. This strict classification underscores the federal government’s view on the severe risks associated with these drugs.

Examples of Schedule I Controlled Substances

The Examples of Schedule I drugs include a range of substances known for their profound psychoactive effects and high potential for dependence or addiction. These substances are often associated with significant public health and safety concerns due to their abuse potential and the absence of recognized medical applications. The Schedule I controlled substances list includes several well-known illicit drugs.

  • Heroin: A highly addictive opioid derived from morphine, known for its rapid onset of euphoric effects.
  • Lysergic Acid Diethylamide (LSD): A potent hallucinogenic drug that alters perception, mood, and thought.
  • 3,4-methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy or Molly: A synthetic drug that produces feelings of increased energy, pleasure, emotional warmth, and distorted sensory and time perception.
  • Marijuana (Cannabis): Although legalized for medical or recreational use in many U.S. states, it remains a Schedule I controlled substance under federal law.
  • Peyote: A small, spineless cactus containing the psychedelic alkaloid mescaline.
  • Psilocybin and Psilocin: The primary psychoactive compounds found in certain species of mushrooms, often referred to as “magic mushrooms.”

These examples illustrate the diverse chemical structures and pharmacological effects of substances categorized under Schedule I, all sharing the common federal legal status of high abuse potential and no accepted medical use.

Federal Classification Criteria for Schedule I Drugs

The Federal Schedule I drug classification is determined by the Drug Enforcement Administration (DEA), in consultation with the Department of Health and Human Services (HHS), based on specific criteria outlined in the Controlled Substances Act. This process involves a thorough evaluation of scientific and medical evidence regarding a substance’s pharmacological effects, its history and current pattern of abuse, the scope, duration, and significance of abuse, and the risk to public health.

The three primary criteria for a substance to be classified as Schedule I are:

  1. It has a high potential for abuse.
  2. It has no currently accepted medical use in treatment in the United States.
  3. There is a lack of accepted safety for use of the drug or other substance under medical supervision.

This stringent classification reflects a federal policy aimed at controlling substances deemed to pose the greatest risk to public health and safety. According to the Centers for Disease Control and Prevention (CDC), drug overdose deaths in the United States exceeded 107,000 in 2021, highlighting the severe public health impact of substances, many of which are classified under the Controlled Substances Act and contribute to these tragic outcomes.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.